Literature DB >> 8093593

Familial differences between rapid neuroleptic response psychosis and delayed neuroleptic response psychosis.

F Sautter1, B McDermott, D Garver.   

Abstract

Recent data suggest that latency of neuroleptic response may be used to separate distinct subtypes of psychotic disorders. In this preliminary study we contrast family patterns of illness of rapid neuroleptic response psychotics and delayed neuroleptic response psychotics. The data show that first-degree relatives of delayed neuroleptic response psychotics evidence higher levels of psychiatric disorder than rapid responders: relatives of delayed neuroleptic response psychotics evidenced a morbid risk for schizophrenic-spectrum disorder that was more than twice as high as the morbid risk for such disorders among relatives of rapid neuroleptic response psychotics. Relatives of delayed neuroleptic responders that received a diagnosis of schizophrenia, schizoaffective, or schizophreniform disorder evidenced significantly more residual impairment than schizophrenic-spectrum relatives of rapid neuroleptic responders. These preliminary data indicate the possibility that latency of therapeutic response to neuroleptic medication may be used to discriminate two familially distinct psychotic disorders and they suggest that delayed neuroleptic response may characterize a familially transmitted poor-outcome disease.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8093593     DOI: 10.1016/0006-3223(93)90273-g

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  3 in total

1.  The long-term effects of placebo in patients with chronic schizophrenia.

Authors:  R J Wyatt; I D Henter; J J Bartko
Journal:  Biol Psychiatry       Date:  1999-10-15       Impact factor: 13.382

2.  The efficacies of clozapine and haloperidol in refractory schizophrenia are related to DTNBP1 variation.

Authors:  Lingjun Zuo; Xingguang Luo; John H Krystal; Joyce Cramer; Dennis S Charney; Joel Gelernter
Journal:  Pharmacogenet Genomics       Date:  2009-06       Impact factor: 2.089

Review 3.  Genetics of schizophrenia: from animal models to clinical studies.

Authors:  Ridha Joober; Patricia Boksa; Chawki Benkelfat; Guy Rouleau
Journal:  J Psychiatry Neurosci       Date:  2002-09       Impact factor: 6.186

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.